Company Overview

Daewoong Pharmaceutical Co., Ltd. was established in 1945. Daewoong is one of Korea 's leading pharmaceutical manufacturers and has a strong reputation for product marketing and aggressive investment in R&D projects. Daewoong's vision is to become a leading healthcare group for improving quality of life. Daewoong is dedicated to the noble responsibility of contributing to the over-all improvement of society by committing all its efforts to produce and provide effective drugs for medical treatment. The trademark logo of Daewoong is distinguished for its creativity as it represents the Chinese character for a “Big Bear”. The bear is considered in Asian mythology as the god of healing and the incarnation of wisdom with powers to cure and prolong life.

Daewoong's sales network is vast, well-organized, and able to reach all areas of Korea . This network is made up of more than 750 highly qualified and motivated medical representatives who possess the strength and desire to successfully market prescription and non-prescription pharmaceuticals, household goods, and consumer products. Daewoong uses state-of-the-art information technology that internally links 31 district sales offices through an elaborate intranet system. All Daewoong medical representatives are provided lap-tops. Daewoong's intranet information highway allows medical representatives to develop, share, and implement successful marketing and sales strategies as well as informing each other on the most current, up-to-date information at nearly real time. An addition, SAP and ERP solutions have made it possible for representatives to compare and evaluate projected and actual sales to assist representatives in reaching their target sales numbers. Sales representatives manage themselves and their customers through the Customer Relationship Management (CRM) system, a system that allows daily web conferencing in order for representatives to discuss and implement the most recent successful sales strategies. Currently, there are 27 product managers at Daewoong who develop and implement marketing strategies for products. Product managers also inform, assist, and promote products to doctors, pharmacists, and medical representatives. Daewoong promotes products using a broad range of programs that include: media advertisement, symposiums, workshops, direct mail, and group detailing. As a result, Daewoong is projected to have more than $500 million USD in sales for 2007.

Daewoong's production facilities are located in Seongnam, a satellite city of Seoul , and Hyangnam, which is located about 60 kilometers away from Seoul . These plants produce tablets, hard and soft capsules, liquids, injections, and bio-products. Both plants have been fully GMP-approved, and their quality control systems have been continuously upgraded to meet the highest level of our quality requirements. In 2003, Daewoong obtained ISO 14001 Certification and OHSAS 18001 Certification. In 2006, Daewoong obtained White Grade GMP (the highest grade) from the Korean Food and Drug Administration (KFDA).

Daewoong's R&D center consists of six teams. They have platform technologies and are involved in projects such as recombinant protein production, chemical synthesis, the development of drug delivery systems, pre-clinical evaluations, and patent strategies. Daewoong R&D center has focused on its core competence in commercializing biological products and has invested in our own exclusive R&D projects for strategic products.

Daewoong has established a worldwide R&D network with universities, bio-venture companies, national institutes, and pharmaceutical companies. The R&D center has invested in projects related to vaccines, genomics, proteomics, and bio-informatics in order to find new drug candidates to reinforce our product pipelines. Daewoong's pipelines consist of growth hormones, EPO, anti-cancer agents, anti-viral drugs, and new vaccines. Daewoong is always seeking new products, ideas, and business opportunities for research co-development and marketing.

Daewoong have collaborated with more than 20 foreign companies. These companies include Eli Lilly, Allergan, Dainippon Eisai, AstraZeneca, and Novartis just to name a few.

Beijing Office

Daewoong has six overseas branch offices in Asia . Our present Beijing representative office was established more than a year ago. Yet, we are already expanding business and are looking to strengthen our staff with excellent researchers who are experienced in chemical pharmaceuticals and biologics. Moreover, Daewoong Pharmaceutical is in the process of acquiring a factory in China to fulfill our needs to provide excellent service and products in China . Our overall goal is to become a highly-respected company by the people of China .

Currently, we are inviting highly enthusiastic and progressive applicants to help us accomplish our vision and goal together.

联系方式：

韩国大熊制药株式会社北京代表处
公司地址：北京市朝阳区东三环中路甲10号赢嘉中心B座806室
邮政编码：100022
公司网址： http://www.daewoong.com